Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Israel, Gulf states report fresh missile and drone attacks - 2Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- 3'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more
- 4People with depression can treat themselves at home with new device
- 51,000-mile Saharan dust storm, from the sky and from the ground
- IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound
- Which Startup's Innovation Could Reform Medical care?
- Merz says army could be involved in mine-clearing from Hormuz
- Promising Speculation Bearings for Portfolio Development in 2024
- German petrol stations hike prices as once-a-day rule takes effect
- German journalists' union condemns attack on reporters in village
- Instructions to Floss Appropriately and Forestall Gum Sickness
- Red Crescent: More than 100,000 civilian structures damaged in Iran
- Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out
